Please provide your email address to receive an email when new articles are posted on . Published results showed lumbar microdiscectomy with a bone-anchored annular closure device for treatment of ...

The MarketWatch News Department was not involved in the creation of this content. BOSTON, Oct. 24, 2025 /PRNewswire/ -- Intrinsic Therapeutics, Inc., the makers of the Barricaid(R) Annular Closure ...

“Advancing OctaSeal into FDA review represents a significant inflection point, not just for Spinol, but for a market that has been underserved for decades. With only one competitor in a ...

The American Medical Association released its CPT 2026 code set, which includes the new CPT code 63032 fr bone-anchored annular closure, Intrinsic Therapeutics said Oct. 24. The new add-on CPT code ...

BOSTON, Sept. 2, 2025 /PRNewswire/ -- Intrinsic Therapeutics, Inc., a medical technology company committed to redefining the standard of care for lumbar discectomy patients with large annular defects ...

Discectomy is a common outpatient spinal procedure, but for patients with large annular defects (>5mm), outcomes can be unpredictable and sometimes devastating. In a session at Becker’s 22nd Spine, ...

BOSTON, March 4, 2026 /PRNewswire/ -- Intrinsic Therapeutics, Inc. has introduced the Barricaid® Narrow Anchor, the next generation of its FDA PMA-approved Barricaid® Bone-Anchored Annular Closure ...

BOSTON, Nov. 12, 2024 /PRNewswire/ -- Intrinsic Therapeutics, a medical technology company driving to change the standard of care for lumbar discectomy patients with large annular defects by reducing ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Published results showed a decrease in the use of ...

Spinol Medical(TM) today announced the advancement of its OctaSeal(TM) Annular Closure System into U.S. FDA review. OctaSeal represents a novel, tubular-based, intradiscal technology designed to close ...

BOSTON, Oct. 24, 2025 /PRNewswire/ -- Intrinsic Therapeutics, Inc., the makers of the Barricaid® Annular Closure Device, announced today that the American Medical Association (AMA) has published a new ...